Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (17816)	1/15/1999 8:55:00 PM
From: AlienTech	Read Replies (1) \| Respond to of 23519

I hear another ole fart kicked the bucket. Found with a woman of ill repute no less. Vice is prob having a field day, maybe they will put Viagra next to the condom machines in strip joints. Less crime, more godly world we will have. Higher moral standards etc etc.. wow I need to buy me some pfe.

To: VLAD who wrote (17816)	1/15/1999 11:21:00 PM
From: Cacaito	Respond to of 23519

Maybe Muse is the remedy for premature ejaculation, that the man ejaculate does not mean that he has to stop the ongoing intercourse, if he can sustain the erection then he could satisfy the partner, even if he already ejaculated. Muse can keep the erection longer than usual and maybe help. Who knows the guy can even get couple of more ejaculation while the erection last (and even things out with the female partner). But, is there a demand for premature ejaculation? do patients go to the doctor in enough numbers? Do doctors know how to handle it? even as a side effect of drugs it is miss a lot, few ask the patient, the patient does not tell. Don't ask, Don't tell. If Muse is the answer who will take the time to 1st get the history and 2nd teach the patient? Even for the clearly easy Muse for ED there is a big gap on patient education ( do not forget the big gap of Non-urologist practitioners, many do not even know the drug exist). The study should not be that expensive, the marketing will be. Vivus can fund the study on its own and let big pharma do the marketing (and pharma take their due 80% chunk of the profits, 60% if Leland has the upper hand). Vlad, good idea. You got my shares.